Tucker Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-167
Closed -$15.9K 461
2025
Q4
$15.9K Buy
+167
New +$16.4K ﹤0.01% 491
2024
Q4
Sell
-45
Closed -$3.96K 1549
2024
Q3
$3.77K Hold
45
﹤0.01% 997
2024
Q2
$3.46K Hold
45
﹤0.01% 1176
2024
Q1
$3.08K Hold
45
﹤0.01% 1219
2023
Q4
$2.6K Sell
45
-4
-8% -$214 ﹤0.01% 1070
2023
Q3
$2.59K Buy
49
+17
+53% +$892 ﹤0.01% 981
2023
Q2
$1.73K Buy
32
+28
+700% +$1.46K ﹤0.01% 887
2023
Q1
$200 Hold
4
﹤0.01% 1103
2022
Q4
$185 Hold
4
﹤0.01% 761
2022
Q3
$172 Buy
+4
New +$160 ﹤0.01% 802
2021
Q2
Sell
-2,390
Closed -$92.4K 348
2021
Q1
$92.4K Sell
2,390
-800
-25% -$30.3K 0.05% 45
2020
Q4
$115K Buy
+3,190
New +$115K 0.07% 33

Other funds holding BSX

Tucker Asset Management's BSX Position: Q1 2026 in Review

Tucker Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 167 shares — an estimated $15.9K sold.

Tucker Asset Management first reported a position in BSX in Q4 2020 and held it in 12 quarters. The position peaked at $115K in Q4 2020. 1,679 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tucker Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 167 Boston Scientific shares in Q1 2026, an estimated $15.9K.
  • Tucker Asset Management first reported a position in Boston Scientific in Q4 2020 and held it in 12 quarters.
  • Tucker Asset Management's Boston Scientific position peaked at $115K in Q4 2020.
  • 1,679 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.